Mark Basil Swindells
Corporate Officer/Principal bij Exscientia AI Ltd.
Actieve functies van Mark Basil Swindells
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Loopbaan van Mark Basil Swindells
Eerdere bekende functies van Mark Basil Swindells
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EXSCIENTIA PLC | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
